RCKTW

ROCKET PHARMACEUTICALS INC

• PUBT·07/08 23:05

  Rocket Pharmaceuticals principal accounting officer Joseph Manhede files initial beneficial ownership statement

• PUBT·06/30 21:16

  Rocket Pharma names Joseph Manhede principal accounting officer, effective July 8

• Seeking Alpha·06/28 12:45

  Regenxbio: 'Strong Buy' On FDA Course Reversal For NAVSUNLI And Potential AA DMD Filing

• PUBT·06/12 11:00

  Rocket Pharmaceuticals sells rare pediatric disease priority review voucher for $180 million

• PUBT·05/28 11:00

  Rocket Pharma to present at Jefferies Global Healthcare Conference

• PUBT·05/26 23:47

  Rocket Pharma CEO Gaurav Shah sells 55,684 shares for $171,787.82

• PUBT·05/21 10:06

  Rocket Pharmaceuticals shareholders approve stock option exchange program at annual meeting

• Reuters·05/07 20:09

  Rocket Pharmaceuticals Q1 net loss narrows on lower expenses

• PUBT·05/07 20:00

  Rocket Pharma Q1 net loss narrows to $47.6 million; R&D expenses fall to $31.5 million

• Reuters·05/07 20:00

  ROCKET PHARMACEUTICALS Q1 NET INCOME USD -47.6 MILLION

• Reuters·04/28 12:53

  ROCKET PHARMACEUTICALS INC <RCKT.O>: LEERINK PARTNERS RAISES TARGET PRICE TO $12 FROM $11

• PUBT·04/28 11:04

  Rocket Pharma sells priority review voucher for $180 million

• Reuters·04/28 11:00

  ROCKET PHARMACEUTICALS INC - CASH RUNWAY EXTENDED INTO SECOND QUARTER OF 2028

• Reuters·04/28 07:25

  U.S. RESEARCH ROUNDUP-Commvault Systems, Domino's Pizza, Organon & Co

• Reuters·04/16 15:37

  UPDATE 1-US FDA's accelerated approval for drugs needs more transparency, says research firm